255 related articles for article (PubMed ID: 4700485)
1. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
Rudman D; Patterson JH; Gibbas DL
J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
[TBL] [Abstract][Full Text] [Related]
2. Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy.
Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Ahmann P; Jordan A; Mosteller RC
J Clin Invest; 1971 Sep; 50(9):1941-9. PubMed ID: 4327577
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variation in the responsiveness of human subjects to human growth hormone.
Rudman D; Friedes D; Patterson JH; Gibbas DL
J Clin Invest; 1973 Apr; 52(4):912-8. PubMed ID: 4693655
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.
Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
J Clin Invest; 1972 May; 51(5):1118-24. PubMed ID: 5057128
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
6. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
8. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
Sulmont V; Brauner R; Fontoura M; Rappaport R
Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
[TBL] [Abstract][Full Text] [Related]
9. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
[TBL] [Abstract][Full Text] [Related]
10. LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: lack of effect of replacement therapy with human growth hormone.
Kelch RP; Markovs M; Huss J
J Clin Endocrinol Metab; 1976 Jun; 42(6):1104-13. PubMed ID: 777020
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
12. Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man.
Heymsfield SB; Bethel RA; Hall EC; Mills JB; Moseley MH; Kostyo JL; Rudman D
J Clin Invest; 1977 Sep; 60(3):563-70. PubMed ID: 142777
[TBL] [Abstract][Full Text] [Related]
13. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
14. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
15. Effect of human growth hormone on adrenal androgens in children with growth hormone deficiency.
Sklar CA; Ulstrom RA
Horm Res; 1984; 20(3):166-71. PubMed ID: 6237972
[TBL] [Abstract][Full Text] [Related]
16. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
[TBL] [Abstract][Full Text] [Related]
18. Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.
Schoenle EJ; Zapf J; Prader A; Torresani T; Werder EA; Zachmann M
J Clin Endocrinol Metab; 1995 Feb; 80(2):374-8. PubMed ID: 7852493
[TBL] [Abstract][Full Text] [Related]
19. Human growth hormone therapy of non-growth hormone deficient children.
Ranke MB
Pediatrician; 1987; 14(3):178-82. PubMed ID: 3331012
[TBL] [Abstract][Full Text] [Related]
20. The response to treatment with pituitary growth hormone: the New Zealand experience.
Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
